FDA-approved non-surgical technology alters heart tissue that triggers atrial fibrillation

UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia. The THERMOCOOL® SF Catheter is an FDA-approved outpatient procedure for an early-stage form of the condition called paroxysmal atrial fibrillation, when recurring symptoms are unresponsive to medicine. … Read the full story from the UC San Diego Health System Newsroom

Dr. Gregory Feld, who directs the Cardiac Electrophysiology Program at the UC San Diego Sulpizio Cardiovascular Center, describes the new treatment in the news release excerpted above.

Gregory Feld, MD, is professor of medicine in clinical cardiovascular medicine. In 2011, he was named to both the national “Top Doctors” list from U.S.News & World Report and the “San Diego’s Top Doctors” list from the San Diego County Medical Society and San Diego Magazine.

%d bloggers like this: